SelectQuote, Inc. operates a direct-to-consumer insurance distribution and healthcare services platform that connects consumers with Medicare, life, and auto and home insurance policies from carrier partners. Its model combines licensed agents, consultative needs analysis, proprietary lead sourcing and routing technology, and commission revenue from policy sales.
Recurring company developments include fiscal earnings, segment results for Senior, Healthcare Services, Life, and Auto & Home, Medicare Advantage policy volume, SelectRx membership and pharmacy economics, prescription drug reimbursement changes, and cash flow and capital-structure updates. SelectQuote also reports initiatives such as the SelectQuote Local franchise channel, research on e-broker access to Medicare Advantage, conference participation, and NYSE listing-standard compliance.
SelectQuote, Inc. (NYSE: SLQT) will have CEO Tim Danker and CFO Raff Sadun participate in a virtual fireside chat at RBC’s Global Healthcare Conference on May 18, 2021, around 1:55 PM ET. They will discuss the fiscal 3rd quarter earnings and the launch of Population Health, aimed at enhancing Senior healthcare outcomes. The chat will also cover the acquisition of Express Med Pharmaceuticals, set to be branded as SelectRx. Additionally, Mr. Danker and Mr. Sadun will hold 1x1 and small group meetings with investors.
SelectQuote reported a remarkable 80% increase in consolidated revenue for Q3 FY2021, reaching $266.9 million, compared to $148.6 million in Q3 FY2020. Net income jumped to $36.5 million, up from $23.7 million, while Adjusted EBITDA rose 48% to $65.2 million. For the nine-month period, revenue surged 92% to $749.4 million, and net income increased by $66.6 million to $127.7 million. CEO Tim Danker highlighted strong growth in Medicare Advantage policies, which grew 112% year-over-year.
SelectQuote, Inc. (NYSE: SLQT) has launched Population Health, a new healthcare services initiative aimed at enhancing medication adherence, health literacy, and patient engagement among seniors. The initiative addresses gaps in healthcare literacy, with a focus on effective communication and support for medication management. SelectQuote also introduced SelectQuote Ventures to pursue strategic partnerships and acquisitions, starting with Express Med Pharmaceuticals. Key partnerships with Value-Based Primary Care providers and a transportation collaboration with Lyft are designed to improve health outcomes for seniors.
SelectQuote, Inc. (NYSE: SLQT) will release its third quarter 2021 financial results after market close on May 11, 2021. CEO Tim Danker and CFO Raff Sadun will host a conference call on the same day at 5:00 pm ET to discuss the results. SelectQuote specializes in unbiased insurance comparisons, boasting a strong agent force and proprietary technology. The company operates three key segments: SelectQuote Senior, SelectQuote Life, and SelectQuote Auto and Home, with SelectQuote Senior being the largest and fastest-growing segment due to increasing Medicare needs.
SelectQuote (NYSE: SLQT) has completed a secondary public offering of 10,600,000 shares at a price of $27.50 per share, sold by certain stockholders, including Brookside Equity Partners. SelectQuote did not receive any proceeds from this offering, which does not change the number of outstanding shares. An additional 1,590,000 shares may be purchased by underwriters within 30 days. Major financial institutions, such as Credit Suisse and Goldman Sachs, acted as bookrunners for this offering. The registration statement was effective as of March 3, 2021.
SelectQuote (NYSE: SLQT) has announced a secondary public offering of 10,600,000 shares of common stock by certain stockholders, priced at $27.50 each. The offering includes a 30-day option for underwriters to purchase an additional 1,590,000 shares. Importantly, SelectQuote will not receive any proceeds, as all shares are sold by the Selling Stockholders, which include Brookside Equity Partners LLC. The offering is scheduled to close on March 8, 2021, pending customary conditions.
SelectQuote (NYSE: SLQT) announced a proposed registered secondary public offering of 10,600,000 shares of common stock by certain stockholders. The offering is being managed by underwriters such as Credit Suisse, Goldman Sachs, and Morgan Stanley, with a 30-day option to purchase an additional 1,590,000 shares. SelectQuote will not sell any shares nor receive any proceeds from the offering, which will not affect the total number of outstanding shares. A registration statement has been filed with the SEC but is not yet effective.
SelectQuote, Inc. (NYSE: SLQT) announced that CEO Tim Danker and CFO Raff Sadun will participate in a fireside chat at Citi’s 2021 Healthcare Services Conference on February 24, 2021, starting at 3:20 PM ET. They will also engage in one-on-one and small group meetings with investors. Founded in 1985, SelectQuote specializes in unbiased insurance comparisons, aiding consumers in choosing suitable policies through skilled agents and proprietary technology. The company's primary segments include SelectQuote Senior, SelectQuote Life, and SelectQuote Auto and Home.
SelectQuote, Inc. (NYSE: SLQT) has appointed Heidy Robertson-Cooper as Vice President of HealthCare Strategy. With a robust background in healthcare policy and value-based care, Robertson-Cooper aims to enhance SelectQuote's value-based care business. Previously with the American Academy of Family Physicians, she brings a wealth of experience in strategic planning and operations. Bob Grant, President of Senior Division, emphasized her capacity for operational improvement and program management will drive growth.
SelectQuote, Inc. (SLQT) reported a remarkable 103% increase in consolidated revenue for Q2 FY 2021, reaching $358.3 million, up from $176.3 million in Q2 FY 2020. Net income surged to $90.4 million, a $51.3 million rise compared to the previous year. Adjusted EBITDA also rose by 88% to $129.5 million. Notably, Senior revenue grew by 127% year-over-year, marking four consecutive quarters of over 100% growth. The company is raising its fiscal year 2021 guidance based on robust performance and agent productivity improvements, highlighting its strong growth potential.